<DOC>
	<DOCNO>NCT00799227</DOCNO>
	<brief_summary>The study evaluate safety efficacy intravitreal dexamethasone implant study eye vitrectomized subject diabetic macular edema . Subjects follow 26 week .</brief_summary>
	<brief_title>Safety Efficacy New Treatment Vitrectomized Subjects With Diabetic Macular Edema</brief_title>
	<detailed_description />
	<mesh_term>Macular Edema</mesh_term>
	<mesh_term>Edema</mesh_term>
	<mesh_term>Dexamethasone acetate</mesh_term>
	<mesh_term>Dexamethasone</mesh_term>
	<mesh_term>Dexamethasone 21-phosphate</mesh_term>
	<mesh_term>BB 1101</mesh_term>
	<criteria>18 year age old diabetic macular edema History vitrectomy Central retinal thickness ≥ 275 µm Visual acuity 20/320 20/40 study eye bad 20/200 eye Known anticipate need ocular surgery study period History glaucoma current high eye pressure require 1 medication Uncontrolled systemic disease Known allergy study medication Known steroidresponder Use systemic steroid Female subject pregnant , nurse planning pregnancy</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>July 2014</verification_date>
</DOC>